📰
Politics
Merck nears $6bn biotech deal to boost cancer drug pipeline
📅25 March 2026 at 00:59
📰Financial Times
👁️0 views
Share:
📰
Article Preview
Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by Financial Times. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.